PATENT CLAIM ANALYSIS

Application Number: 16358410
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "133100"]

Abstract:
Provided herein are methods of treating B-cell proliferative disorders in particular Follicular Lymphoma and/or Diffuse Large B-Cell Lymphoma using immunoconjugates comprising anti-CD79b antibodies in combination with additional therapeutic agents.

Claim (Index 65):
The method of  claim 60 , wherein the immunoconjugate comprises the formula: wherein Ab is an anti-CD79b antibody comprising (i) an HVR-H1 comprising the amino acid sequence of SEQ ID NO: 21; (ii) an HVR-H2 comprising the amino acid sequence of SEQ ID NO: 22; (iii) an HVR-H3 comprising the amino acid sequence of SEQ ID NO: 23; (iv) an HVR-L1 comprising the amino acid sequence of SEQ ID NO: 24; (v) an HVR-L2 comprising the amino acid sequence of SEQ ID NO: 25; and (vi) an HVR-L3 comprising the amino acid sequence of SEQ ID NO: 26, and wherein Val is valine, Cit is citrulline, and p is between 1 and 8.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.07143
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13973669', '13760751', '15349964', '11754899', '14960015']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7775452261554899
- 35 USC 102 Novelty (BERT): 0.5789310745190487
- Combined Prediction Score: 0.7576838109918459
- Mean Citation Score: 451.129036
- Max Citation Score: 461.6173
- Similarity Product: 359.80218381340507

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test